Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Why do we still cling to spirometry for assessing small airway function?

Frederik Trinkmann, Henrik Watz, Felix J.F. Herth
European Respiratory Journal 2020 56: 2001071; DOI: 10.1183/13993003.01071-2020
Frederik Trinkmann
1Pneumology and Critical Care Medicine, Thoraxklinik at University Hospital Heidelberg, Translational Lung Research Center Heidelberg (TLRC), Member of German Center for Lung Research (DZL), Heidelberg, Germany
2Dept of Biomedical Informatics of the Heinrich-Lanz-Center, University Medical Center Mannheim, Heidelberg University, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Frederik Trinkmann
  • For correspondence: frederik.trinkmann@med.uni-heidelberg.de
Henrik Watz
3Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix J.F. Herth
1Pneumology and Critical Care Medicine, Thoraxklinik at University Hospital Heidelberg, Translational Lung Research Center Heidelberg (TLRC), Member of German Center for Lung Research (DZL), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Small airway function comprises heterogenous interactions between ventilation, diffusion, perfusion and inflammation that cannot be covered by spirometry https://bit.ly/2LiyQ5E

To the Editor:

With great interest we read the article by Arshad et al. [1] and the accompanying editorial [2] in the March 2020 issue of the European Respiratory Journal. We fully agree that early detection and small airway function are both of utmost importance for the management of obstructive lung disease. However, we have some methodological concerns in this context. These should be discussed as certain imitations of the important work at hand.

Since James Hogg's ground-breaking publication in the New England Journal of Medicine, more than 50 years have now passed [3]. Ever since, it has been discussed that considerable destruction must be present in the small airways before it can be detected clinically or with commonly used diagnostic tests [4, 5]. The latter has not much changed, neither in clinical routine nor research until today. Therefore, the small airways still remain what was previously described as “the lung's quiet zone” [6]. This is important, as the small airways are increasingly recognised to be involved early in the pathogenesis of both bronchial asthma and COPD. Hence, the work by Arshad et al. [1] tackles an important topic and potentially provides a link between both entities. We agree that forced expiratory flow at 25–75% of forced vital capacity (FEF25–75) intuitively is more sensitive than parameters of central obstruction, such as forced expiratory volume in 1 s alone [1, 2]. However, we want to emphasise that small airway function should not be simply reduced to airway obstruction. In contrast, small airway function comprises heterogenous interactions between ventilation, diffusion, perfusion and inflammation.

Publication of the cross-sectional results from ATLANTIS revealed that small airway function is impaired in over 90% of asthmatic patients [7]. These changes cannot be addressed by spirometric parameters alone, which must be considered as rather insensitive in general. Recent studies further underline these findings. More advanced techniques, such as multiple breath washout (MBW) testing and oscillometry were demonstrated to be feasible in asthmatic patients. Both add considerable information for the differentiation of asthmatic patients with normal spirometry from non-asthmatic controls, respectively [8]. Likewise, parameters of oscillometry outperformed spirometric parameters for differentiating patients at risk for the development of COPD from healthy controls, as well as from diagnosed COPD patients [9]. Most notably, diagnostic performance of FEF25–75 was just above chance when being used as a single parameter. This also has clinical implications. Lately, oscillometry was shown to be more sensitive than spirometry in identifying bronchodilator response as well as patients with poor asthma control [10].

Oscillometry is recognised as one of the most promising techniques for assessing small airway function in research and clinical practice. This is not only because of the recently demonstrated direct relationship to peripheral obstruction [11]. In contrast to spirometry, oscillometry uses tidal breathing not requiring forced and artificial manoeuvres. This makes it easily applicable, even in early childhood. However, we also see other additional techniques to be valuable in the assessment of small airway function. These include, but are not limited to, well-known conventional tests such as body plethysmography and transfer factor for carbon monoxide (formerly “diffusing capacity”). In addition, more advanced functional techniques such as MBW, capnovolumetry or fractional exhaled nitric oxide are now clinically available. Capnovolumetry seems to be especially interesting for detection of peripheral obstruction in outpatient settings [12], being both inexpensive and easy to perform. Imaging techniques comprise quantitative computed tomography or magnetic resonance imaging. Available data strongly supports the idea of combined approaches. Neither a single test nor even a distinct parameter will ever be sufficient for future assessment of small airway function. The aforementioned techniques provide information about the small airways while addressing different aspects (figure 1).

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Diagnostic tools. Schematic overview of conventional, advanced and imaging techniques for assessment of small airway function with the respective aspects addressed.

We believe that it is important to longitudinally assess lung function changes together with risk factors, as proposed in the Isle of Wight Birth Cohort Study. We are aware that today's technology was not readily available at the time of planning the cohort. However, when started today, research should also include more sensitive measures of early changes. There are currently several ongoing multicentre studies investigating both childhood and adult asthma. For example, both the ATLANTIS [7] and ALLIANCE [13] cohorts include measurements of small airway function over time. They will provide additional mechanistic insights into the development and course of disease.

Taken together, those days for spirometry as sole assessment of airway function should be long gone. It is often argued that world-wide availability of other methods is not given, and we want to emphasise that spirometry is not worthless for managing airway disease in general. However, its use for early detection of airway disease is limited. Spirometry should be reasonably extended by techniques aiming, in particular, at small airway function, as they provide additional information. Their final value remains to be determined in future research. However, the availability of such methods must not hinder scientific progress.

Shareable PDF

Supplementary Material

This one-page PDF can be shared freely online.

Shareable PDF ERJ-01071-2020.Shareable

Footnotes

  • Conflict of interest: F. Trinkmann reports personal fees from Actelion, Berlin Chemie, Boehringer Ingelheim, Chiesi, Novartis, Mundipharma, TEVA, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline and Roche, outside the submitted work.

  • Conflict of interest: H. Watz has nothing to disclose.

  • Conflict of interest: F.J.F. Herth has nothing to disclose.

  • Received April 7, 2020.
  • Accepted May 6, 2020.
  • Copyright ©ERS 2020
https://www.ersjournals.com/user-licence

References

  1. ↵
    1. Arshad SH,
    2. Hodgekiss C,
    3. Holloway JW, et al.
    Association of asthma and smoking with lung function impairment in adolescence and early adulthood: the Isle of Wight Birth Cohort Study. Eur Respir J 2020; 55: 1900477. doi:10.1183/13993003.00477-2019
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Polverino F,
    2. Soriano JB
    . Small airways and early origins of COPD: pathobiological and epidemiological considerations. Eur Respir J 2020; 55: 1902457. doi:10.1183/13993003.02457-2019
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Hogg JC,
    2. Macklem PT,
    3. Thurlbeck WM
    . Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278: 1355–1360. doi:10.1056/NEJM196806202782501
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Hogg JC,
    2. Pare PD,
    3. Hackett TL
    . The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Physiol Rev 2017; 97: 529–552. doi:10.1152/physrev.00025.2015
    OpenUrlCrossRefPubMed
  5. ↵
    1. Stockley JA,
    2. Cooper BG,
    3. Stockley RA, et al.
    Small airways disease: time for a revisit? Int J Chron Obstruct Pulmon Dis 2017; 12: 2343–2353. doi:10.2147/COPD.S138540
    OpenUrl
  6. ↵
    1. Mead J
    . The lung's “quiet zone”. N Engl J Med 1970; 282: 1318–1319. doi:10.1056/NEJM197006042822311
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Postma DS,
    2. Brightling C,
    3. Baldi S, et al.
    Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study. Lancet Respir Med 2019; 7: 402–416. doi:10.1016/S2213-2600(19)30049-9
    OpenUrl
  8. ↵
    1. Trinkmann F,
    2. Lenz SA,
    3. Schafer J, et al.
    Feasibility and clinical applications of multiple breath wash-out (MBW) testing using sulphur hexafluoride in adults with bronchial asthma. Sci Rep 2020; 10: 1527. doi:10.1038/s41598-020-58538-x
    OpenUrl
  9. ↵
    1. Su ZQ,
    2. Guan WJ,
    3. Li SY, et al.
    Significances of spirometry and impulse oscillometry for detecting small airway disorders assessed with endobronchial optical coherence tomography in COPD. Int J Chron Obstruct Pulmon Dis 2018; 13: 3031–3044. doi:10.2147/COPD.S172639
    OpenUrl
  10. ↵
    1. Cottee AM,
    2. Seccombe LM,
    3. Thamrin C, et al.
    Bronchodilator response assessed by the forced oscillation technique identifies poor asthma control with greater sensitivity than spirometry. Chest 2020; 157: 1435–1441.
    OpenUrl
  11. ↵
    1. Foy BH,
    2. Soares M,
    3. Bordas R, et al.
    Lung computational models and the role of the small airways in asthma. Am J Respir Crit Care Med 2019; 200: 982–991. doi:10.1164/rccm.201812-2322OC
    OpenUrl
  12. ↵
    1. Kellerer C,
    2. Jankrift N,
    3. Jorres RA, et al.
    Diagnostic accuracy of capnovolumetry for the identification of airway obstruction – results of a diagnostic study in ambulatory care. Respir Res 2019; 20: 92. doi:10.1186/s12931-019-1067-1
    OpenUrl
  13. ↵
    1. Fuchs O,
    2. Bahmer T,
    3. Weckmann M, et al.
    The all age asthma cohort (ALLIANCE) – from early beginnings to chronic disease: a longitudinal cohort study. BMC Pulm Med 2018; 18: 140. doi:10.1186/s12890-018-0705-6
    OpenUrl
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 56 Issue 1 Table of Contents
European Respiratory Journal: 56 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Why do we still cling to spirometry for assessing small airway function?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Why do we still cling to spirometry for assessing small airway function?
Frederik Trinkmann, Henrik Watz, Felix J.F. Herth
European Respiratory Journal Jul 2020, 56 (1) 2001071; DOI: 10.1183/13993003.01071-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Why do we still cling to spirometry for assessing small airway function?
Frederik Trinkmann, Henrik Watz, Felix J.F. Herth
European Respiratory Journal Jul 2020, 56 (1) 2001071; DOI: 10.1183/13993003.01071-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • D-dimer cut-offs and machine learning for ruling out pulmonary embolism
  • Sputum cell counts in COPD patients who use electronic cigarettes
  • Extracorporeal life support allows lung transplant in rapidly progressive ILD
Show more Agora

Correspondence

  • Extracorporeal life support as a bridge to lung transplantation strategy in anti-MDA5+ rapidly progressive interstitial lung disease is life-saving but with persistent difficulties at the bedside
  • Liver cancer in severe alpha-1 antitrypsin deficiency: Who is at risk?
  • Cancer risk in severe alpha-1-antitrypsin deficiency - the importance of the early identification
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society